Effects of verapamil on postextrasystolic potentiation

Aryan N. Mooss, Daniel E. Hilleman, J. Rysavy, M. H. Sketch

Research output: Contribution to journalArticle

Abstract

To assess the effects of verapamil on postextrasystolic potentiation (PESP), contrast left ventriculography was performed in ten healthy anesthetized dogs before and after the intravenous administration of verapamil, 0.1 mg/kg. During the contrast ventriculography, a single atrial premature stimulus was introduced. Ejection fractions of a control beat and postpremature beat were measured before and after verapamil. Before verapamil, the mean ejection fractions of the control beat and the postpremature beat were 60±10 percent and 67±10 percent, respectively (p

Original languageEnglish
Pages (from-to)1438-1441
Number of pages4
JournalChest
Volume101
Issue number5
StatePublished - 1992

Fingerprint

Verapamil
Intravenous Administration
Dogs

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Mooss, A. N., Hilleman, D. E., Rysavy, J., & Sketch, M. H. (1992). Effects of verapamil on postextrasystolic potentiation. Chest, 101(5), 1438-1441.

Effects of verapamil on postextrasystolic potentiation. / Mooss, Aryan N.; Hilleman, Daniel E.; Rysavy, J.; Sketch, M. H.

In: Chest, Vol. 101, No. 5, 1992, p. 1438-1441.

Research output: Contribution to journalArticle

Mooss, AN, Hilleman, DE, Rysavy, J & Sketch, MH 1992, 'Effects of verapamil on postextrasystolic potentiation', Chest, vol. 101, no. 5, pp. 1438-1441.
Mooss, Aryan N. ; Hilleman, Daniel E. ; Rysavy, J. ; Sketch, M. H. / Effects of verapamil on postextrasystolic potentiation. In: Chest. 1992 ; Vol. 101, No. 5. pp. 1438-1441.
@article{bb79457207fa4d1ead9a03c48a374c24,
title = "Effects of verapamil on postextrasystolic potentiation",
abstract = "To assess the effects of verapamil on postextrasystolic potentiation (PESP), contrast left ventriculography was performed in ten healthy anesthetized dogs before and after the intravenous administration of verapamil, 0.1 mg/kg. During the contrast ventriculography, a single atrial premature stimulus was introduced. Ejection fractions of a control beat and postpremature beat were measured before and after verapamil. Before verapamil, the mean ejection fractions of the control beat and the postpremature beat were 60±10 percent and 67±10 percent, respectively (p",
author = "Mooss, {Aryan N.} and Hilleman, {Daniel E.} and J. Rysavy and Sketch, {M. H.}",
year = "1992",
language = "English",
volume = "101",
pages = "1438--1441",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "5",

}

TY - JOUR

T1 - Effects of verapamil on postextrasystolic potentiation

AU - Mooss, Aryan N.

AU - Hilleman, Daniel E.

AU - Rysavy, J.

AU - Sketch, M. H.

PY - 1992

Y1 - 1992

N2 - To assess the effects of verapamil on postextrasystolic potentiation (PESP), contrast left ventriculography was performed in ten healthy anesthetized dogs before and after the intravenous administration of verapamil, 0.1 mg/kg. During the contrast ventriculography, a single atrial premature stimulus was introduced. Ejection fractions of a control beat and postpremature beat were measured before and after verapamil. Before verapamil, the mean ejection fractions of the control beat and the postpremature beat were 60±10 percent and 67±10 percent, respectively (p

AB - To assess the effects of verapamil on postextrasystolic potentiation (PESP), contrast left ventriculography was performed in ten healthy anesthetized dogs before and after the intravenous administration of verapamil, 0.1 mg/kg. During the contrast ventriculography, a single atrial premature stimulus was introduced. Ejection fractions of a control beat and postpremature beat were measured before and after verapamil. Before verapamil, the mean ejection fractions of the control beat and the postpremature beat were 60±10 percent and 67±10 percent, respectively (p

UR - http://www.scopus.com/inward/record.url?scp=0026636529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026636529&partnerID=8YFLogxK

M3 - Article

C2 - 1374699

AN - SCOPUS:0026636529

VL - 101

SP - 1438

EP - 1441

JO - Chest

JF - Chest

SN - 0012-3692

IS - 5

ER -